Id |
Subject |
Object |
Predicate |
Lexical cue |
T62 |
1-11 |
VBZ |
denotes |
correlates |
T63 |
12-16 |
IN |
denotes |
with |
T64 |
17-25 |
NN |
denotes |
severity |
T65 |
25-26 |
-COMMA- |
denotes |
, |
T66 |
27-38 |
NN |
denotes |
criticality |
T67 |
38-39 |
-COMMA- |
denotes |
, |
T68 |
40-45 |
JJ |
denotes |
viral |
T69 |
46-50 |
NN |
denotes |
load |
T70 |
50-51 |
-COMMA- |
denotes |
, |
T71 |
52-55 |
CC |
denotes |
and |
T72 |
56-65 |
NN |
denotes |
prognosis |
T73 |
66-68 |
IN |
denotes |
of |
T74 |
69-77 |
NN |
denotes |
COVID-19 |
T75 |
79-80 |
IN |
denotes |
• |
T76 |
82-93 |
NNP |
denotes |
Tocilizumab |
T77 |
93-94 |
-COMMA- |
denotes |
, |
T78 |
95-97 |
DT |
denotes |
an |
T79 |
98-106 |
NN |
denotes |
anti-IL6 |
T80 |
106-107 |
-COMMA- |
denotes |
, |
T81 |
108-111 |
MD |
denotes |
can |
R57 |
T62 |
T63 |
arg1Of |
correlates,with |
R58 |
T71 |
T63 |
arg2Of |
and,with |
R59 |
T64 |
T65 |
arg1Of |
severity,"," |
R60 |
T66 |
T65 |
arg2Of |
criticality,"," |
R61 |
T65 |
T67 |
arg1Of |
",","," |
R62 |
T69 |
T67 |
arg2Of |
load,"," |
R63 |
T69 |
T68 |
arg1Of |
load,viral |
R64 |
T71 |
T70 |
arg1Of |
and,"," |
R65 |
T67 |
T71 |
arg1Of |
",",and |
R66 |
T72 |
T71 |
arg2Of |
prognosis,and |
R67 |
T72 |
T73 |
arg1Of |
prognosis,of |
R68 |
T74 |
T73 |
arg2Of |
COVID-19,of |
R70 |
T76 |
T77 |
arg1Of |
Tocilizumab,"," |
R71 |
T79 |
T77 |
arg2Of |
anti-IL6,"," |
R72 |
T79 |
T78 |
arg1Of |
anti-IL6,an |
R74 |
T76 |
T81 |
arg1Of |
Tocilizumab,can |